SCS Capital Management LLC Takes $3.60 Million Position in Danaher Corporation $DHR

SCS Capital Management LLC purchased a new position in Danaher Corporation (NYSE:DHR) during the second quarter, Holdings Channel.com reports. The institutional investor purchased 18,888 shares of the conglomerate’s stock, valued at approximately $3,598,000.

Other hedge funds have also recently added to or reduced their stakes in the company. High Note Wealth LLC lifted its holdings in Danaher by 19.2% in the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after purchasing an additional 47 shares in the last quarter. First Command Advisory Services Inc. raised its position in shares of Danaher by 4.4% in the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after buying an additional 47 shares during the last quarter. GW&K Investment Management LLC raised its position in shares of Danaher by 8.4% in the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock valued at $138,000 after buying an additional 47 shares during the last quarter. Kestra Private Wealth Services LLC lifted its stake in shares of Danaher by 0.3% in the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after buying an additional 48 shares in the last quarter. Finally, SOL Capital Management CO lifted its stake in shares of Danaher by 2.7% in the fourth quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock worth $430,000 after buying an additional 50 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Price Performance

Danaher stock opened at $202.51 on Monday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The stock has a market cap of $142.37 billion, a P/E ratio of 35.97, a PEG ratio of 2.52 and a beta of 0.78. The company has a 50-day moving average price of $193.14 and a 200 day moving average price of $192.91. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.77 EPS. Sell-side analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

DHR has been the subject of several research reports. Piper Sandler assumed coverage on shares of Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective for the company. Argus decreased their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. HSBC lowered their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Citigroup started coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target for the company. Finally, Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.